NSE filing, NSE: LENSKART. Summary written from the filing by ALFA Finder's alert engine.
Lenskart Solutions Ltd: key numbers
- Share price
- ₹689.70
- Market cap
- ₹1,19,920 Cr
- Revenue (annual)
- ₹8,814 Cr
- Net profit (annual)
- ₹493.6 Cr
- P/E (TTM)
- 183.0×Sector 49.0×
- Promoter holding
- 17.52%-0.01% QoQ
- FII holding
- 18.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lenskart Solutions Ltd
All →Lenskart Solutions Board Meeting Date
Lenskart Solutions Limited scheduled a board meeting for November 4, 2026, to consider and approve its unaudited standalone and consolidated financial results for the September 2026 quarter.
Lenskart Solutions Legal & Regulatory
Lenskart Solutions Limited received a customs duty demand and penalty order totaling ₹13.17 Crore. The Company intends to challenge this order-in-original regarding the classification of imported optical eyeframes.
- Value
- ₹13.17 Cr
- From
- Office of the Principal Commissioner of Customs
Lenskart Solutions Other Announcement
Lenskart filed its quarterly reconciliation of share capital audit report under Regulation 76. This is routine statutory compliance paperwork with no transactional value.
Lenskart Solutions Employee Stock Options
Lenskart Solutions Limited granted 3,42,000 employee stock options to eligible employees, with an exercise price of Rs. 508 per share under its 2021 ESOP plan.
Lenskart Solutions Acquisition Worth ₹2.71 Cr
Lenskart's subsidiary, NESO Brands, acquired an additional 2.52% stake in Le Petit Lunetier Paris SAS for INR 2.71 Crore. This strategic move expands its brand portfolio.
- Value
- ₹2.71 Cr
Lenskart Solutions Capital Structure Change
Platinum Jasmine A 2018 Trust sold 3.5 crore on-market Lenskart shares, reducing stake from 9.77% to 7.75%. No transaction price disclosed.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date